Maharashtra FDA Orders FIR Against Snapdeal CEO Kunal Bahl

01/05/2015 5:05 PM IST | Updated 15/07/2016 8:25 AM IST
MANJUNATH KIRAN via Getty Images
Co-Founder and CEO of Snapdeal Kunal Bahl gestures while addressing the media in Bangalore on April 8, 2015. India's largest online marketplace Snapdeal on April 8 announced that it has acquired 'FreeCharge' India's fastest growing mobile transactions platform, said to be one of the biggest acquisitions in the history of the Internet industry in India. AFP PHOTO/Manjunath KIRAN (Photo credit should read MANJUNATH KIRAN/AFP/Getty Images)

MUMBAI -- Maharashtra's Food and Drugs Administration (FDA) has ordered an FIR against e-commerce major's CEO Kunal Bahl in a case related to alleged online sale of medicines including prescription drugs.

FDA Commissioner Harshadeep Kamble told reporters on Friday that filing of an FIR has been ordered against directors of the companies too. "According to the law, only a licensed retailer can sell drugs, and that too on the basis of prescription of a doctor," Kamble said, adding such type of online sale of drugs is not allowed as self medication can be harmful.

FDA asked the company to furnish details of the drugs offered for sale, distribution and exhibited for sale on its website

Last month, FDA had raided the company's premises in Mumbai in this regard. At the time, Snapdeal had said it was delisting the drugs from its portal and assisting the regulator in the investigation.

The raid followed FDA receiving information that various medicines, including prescription drugs, were being sold online through

The company spokesperson did not offer any immediate comment.

Like Us On Facebook |
Follow Us On Twitter |
Contact HuffPost India

More On This Topic